Reverse Remodeling Effects of Sacubitril-Valsartan: Structural and Functional Optimization in Stage C Heart Failure
Sacubitril-valsartan, an angiotensin receptor-neprilysin inhibitor, reduces all-cause mortality
and the rate of heart failure hospitalizations in patients with heart failure with reduced …
and the rate of heart failure hospitalizations in patients with heart failure with reduced …
The reverse remodeling response to sacubitril/valsartan therapy in heart failure with reduced ejection fraction
P Martens, H Beliën, M Dupont… - Cardiovascular …, 2018 - Wiley Online Library
Background Major classes of medical therapy for heart failure with reduced ejection fraction
(HFrEF) induce reverse remodeling. The revere remodeling response to sacubitril/valsartan …
(HFrEF) induce reverse remodeling. The revere remodeling response to sacubitril/valsartan …
[HTML][HTML] Effects and clinical implications of sacubitril/valsartan on left ventricular reverse remodeling in patients affected by chronic heart failure: a 24-month follow-up
Background Compared to angiotensin inhibition, angiotensin-neprilysin “blockade”
improves mortality and reduces hospitalizations in patients with heart failure (HF) with …
improves mortality and reduces hospitalizations in patients with heart failure (HF) with …
[HTML][HTML] Ejection fraction improvement and reverse remodeling achieved with Sacubitril/Valsartan in heart failure with reduced ejection fraction patients
A Almufleh, J Marbach, S Chih, E Stadnick… - American journal of …, 2017 - ncbi.nlm.nih.gov
Background: Sacubitril/Valsartan has been shown to improve mortality and reduce
hospitalizations in patients with heart failure with reduced ejection fraction (HFrEF). The …
hospitalizations in patients with heart failure with reduced ejection fraction (HFrEF). The …
Left ventricular reverse remodeling following initiation of sacubitril/valsartan for heart failure with reduced ejection fraction and low blood pressure
Y Nishihara, M Nishimori, T Sawa, K Uemura, S Nagai… - Heart and Vessels, 2024 - Springer
Sacubitril/valsartan has become an important first-line drug for symptomatic heart failure
(HF) patients, especially with left ventricular (LV) ejection fraction (LVEF)< 50%. However …
(HF) patients, especially with left ventricular (LV) ejection fraction (LVEF)< 50%. However …
Do the remodeling effects of sacubitril/valsartan treatment depend upon heart failure duration?
A Villani, S Ravaro, P Cerea, S Caravita… - Journal of …, 2020 - journals.lww.com
Aims The angiotensin receptor and neprilysin inhibitor (ARNI) sacubitril/valsartan (LCZ696)
is recommended for the treatment of patients with heart failure in New York Heart …
is recommended for the treatment of patients with heart failure in New York Heart …
[HTML][HTML] Effect of sacubitril/valsartan on cardiac remodeling compared with other renin–angiotensin system inhibitors: a difference-in-difference analysis of propensity …
Background In patients with heart failure with reduced ejection fraction (HFrEF), treatment
with sacubitril–valsartan (S/V) may reverse left ventricular remodeling (rLVR). Whether this …
with sacubitril–valsartan (S/V) may reverse left ventricular remodeling (rLVR). Whether this …
Dose-response to sacubitril/valsartan in patients with heart failure and reduced ejection fraction
Background Doses of sacubitril/valsartan (Sac/Val) achieved in clinical trials of heart failure
with reduced ejection fraction (HFrEF) are often not reached in clinical practice. Objectives …
with reduced ejection fraction (HFrEF) are often not reached in clinical practice. Objectives …
[HTML][HTML] Sacubitril/valsartan improves left ventricular ejection fraction and reverses cardiac remodeling in Taiwanese patients with heart failure and reduced ejection …
LW Liu, PC Wu, MY Chiu, PF Tu… - Acta Cardiologica Sinica, 2020 - ncbi.nlm.nih.gov
Background The angiotensin receptor-neprilysin inhibitor sacubitril/valsartan is known to
improve outcomes of cardiac death and hospitalization due to heart failure in patients with …
improve outcomes of cardiac death and hospitalization due to heart failure in patients with …
Dose titration of sacubitril/valsartan for heart failure with reduced ejection fraction: a real‐world study
C Wang, Z Lin, D Miao, H Zhang, K Fu… - ESC Heart …, 2023 - Wiley Online Library
Aims The study aims to explore the real‐world titration patterns of sacubitril/valsartan in a
chronic heart failure (HF) follow‐up management system and the effect on the recovery of …
chronic heart failure (HF) follow‐up management system and the effect on the recovery of …
相关搜索
- heart failure sacubitril valsartan
- heart failure ejection fraction
- sacubitril valsartan ejection fraction
- sacubitril valsartan cardiac remodeling
- heart failure reverse remodeling
- sacubitril valsartan taiwanese patients
- sacubitril valsartan dose titration
- sacubitril valsartan propensity score
- heart failure taiwanese patients
- sacubitril valsartan clinical implications
- sacubitril valsartan blood pressure
- heart failure dose titration
- heart failure clinical implications
- heart failure blood pressure
- sacubitril valsartan remodeling effects
- sacubitril valsartan reverse remodeling